[1] Weber C,Noels H.Atherosclerosis: current pathogenesis and therapeutic options[J].Nat Med, 2011,17(11):1410-1422.
[2] 周晓辉,贺春钰.缺血性脑血管病与颈动脉粥样硬化及其危险因素的关系[J].临床神经病学杂志,2005,18(5):370-372.
[3] AKang S,Wu Y,Li X.Effects of statin therapy on the progression of carotid atherosclerosis:a systematic review and meta-analysis[J]. Atherosclerosis,2004,177(2):433-442.
[4] Williams JK,Sukhova GK,Herrington DM,et al.Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[J].J Am Coll Cardiol,1998,31(3):684-691.
[5] Ross R.Atherosclerosis--an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
[6] Moghadasian MH.Experimental atherosclerosis:a historical overview[J].Life Sci,2002,70(8):855-865.
[7] Danesh J,Wheeler JG,Hirschfield GM,et al.C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J].N Engl J Med,2004,350(14):1387-1397.
[8] 许寅宏,徐恩.血清同型半胱氨酸与脑梗死患者颈动脉粥样硬化斑块稳定性的关系[J].中风与神经疾病杂志,2014,31(7):603-605.
[9] Liu X,Shi M,Xia F,et al.The China Stroke Secondary Prevention Trial(CSSPT) protocol:a double-blinded,randomized,controlled trial of combined folic acid and B vitamins for secondary prevention of stroke[J].Int J Stroke,2015,10(2):264-268.
[10] 卫东,方岩,王经忠.血清纤维蛋白原、同型半胱氨酸及颈动脉斑块特征与复发性脑梗死的相关性研究[J].中华临床医师杂志(电子版),2015,9(11):2046-2050.
[11] Jaeger BR,Labarrere CA.Fibrinogen and atherothrom-bosis: vulnerable plaque orvulnerable patient[J].Herz,2003,28(6):530-538.
[12] 高志强,柏燕燕.氯吡格雷联合蚓激酶治疗对急性脑梗死患者血浆D-二聚体、血小板聚集和纤维蛋白原的影响[J].江苏医药,2014,40(14):1707-1708.
[13] 刘怀翔,谈晓牧,刘建国,等.负荷后同型半胱氨酸水平在脑梗死再发缺血性血管事件的随访研究[J].中华老年医学杂志,2014,33(3):246-249.
[14] Jaeger BR,Labarrere CA.Fibrinogen and atherothrombosis:vulnerable plaque orvulnerable patient?[J].Herz,2003,28(6):530-538.
[15] Engström G,Lind P, Hedblad B, et al.Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men[J].Circulation,2002,105(22):2632-2637.
[16] Bots ML,Ford I,Lloyd SM,et al.Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial[J].Stroke,2014,45(8)2348-2353.
[17] Stachowska E,Dolegowska B,Dziedziejko V,et al.Prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) synthesis is regulated by conjugated linoleic acids (CLA) in human macrophages[J]. J Physiol Pharmacol,2009,60(1):77-85
[18] Ray KK,Kastelein JJ,Boekholdt SM,et al.The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults:the good the bad and the uncertain:a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011[J].Eur Heart J,2014,35(15):960-968.
[19] Qi Y,Fan J,Jing L,et al.Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study[J].J Am Coll Cardiol,2015,65(4):355-363.
[20] Mora S,Glynn RJ,Ridker PM.High-density lipoprotein cholesterol,size,particlenumber,and residual vascular risk after potent statin therapy[J].Circulation,2013,128(11):1189-1197.
[21] Luscher TF,Landmesser U,Von Eckardstein A,et al.High-density lipoprotein:vascular protective effects,dysfunction,and potential as therapeutic target[J].Circ Res,2014,114(1):171-182.
[22] Wiberg B,Lind PM,Lind L.Serum levels of monobenzylphthalate (MBzP) is related to carotid atherosclerosis in the elderly[J].Environ Res,2014,133:348-352. |
